Patents by Inventor Antonius Arnoldus Christiaan Jacobs

Antonius Arnoldus Christiaan Jacobs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11103569
    Abstract: The present invention pertains to a vaccine comprising an IgM protease antigen of Streptococcus suis, for use in a method for protecting pigs against an infection with Streptococcus suis of serotype 2 and against an infection with Streptococcus suis of serotype 9.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: August 31, 2021
    Assignee: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Publication number: 20210252124
    Abstract: The present invention pertains to a vaccine comprising (a) an immunologically effective amount of a Streptococcus suis IgM protease antigen, (b) an immunologically effective amount of an Escherichiacoli fibmrial antigen, and (c) an immunologically effective amount of a Clostridium toxoid, and also pertains to use of the vaccine in a method for protecting pigs against a pathogenic infection with Streptococcus suis, Escherichia coli and Clostridium.
    Type: Application
    Filed: August 26, 2019
    Publication date: August 19, 2021
    Applicant: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Publication number: 20210030862
    Abstract: The present invention pertains to a vaccine comprising an IgM protease antigen of Streptococcus suis, for use in a method for protecting pigs against an infection with Streptococcus suis of serotype 2 and against an infection with Streptococcus suis of serotype 9.
    Type: Application
    Filed: December 14, 2018
    Publication date: February 4, 2021
    Applicant: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Publication number: 20200384102
    Abstract: The invention pertains to a vaccine comprising in combination non-replicating immunogens of Erysipelothrix rhusiopathiae, porcine parvo virus, Leptospira interrogans and live attenuated PRRS virus, and a pharmaceutically acceptable carrier, for use in a method for prophylactic treatment of a swine against an infection with Erysipelothrix rhusiopathiae, porcine parvo virus, Leptospira interrogans and PRRS virus, wherein the vaccine is administered in a single dose with regard to the treatment against an infection with PRRS virus.
    Type: Application
    Filed: November 28, 2017
    Publication date: December 10, 2020
    Applicant: Intervet Inc.
    Inventors: Erwin Born van den, Antonius Arnoldus Christiaan Jacobs, Melanie Sno
  • Patent number: 10751405
    Abstract: The present invention pertains to a vaccine comprising non live Lawsonia intracellularis antigen and a pharmaceutically acceptable carrier for use in a method to reduce in a pig the negative impact on average daily weight gain (ADWG) associated with subclinical infection with Lawsonia intracellularis, by systemic administration of the vaccine to the pig.
    Type: Grant
    Filed: February 3, 2016
    Date of Patent: August 25, 2020
    Assignee: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Patent number: 10751403
    Abstract: The present invention pertains to a vaccine comprising an IgM protease antigen of Streptococcus suis, for use in a method wherein a female pig is vaccinated in order to protect a piglet against Streptococcus suis through the intake of colostrum of the vaccinated female pig.
    Type: Grant
    Filed: April 17, 2019
    Date of Patent: August 25, 2020
    Assignee: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Publication number: 20200206336
    Abstract: The present invention pertains to a vaccine comprising an IgM protease antigen of Streptococcus suis, for use in a method for protecting piglets having maternally derived anti-Streptococcus suis antibodies against Streptococcus suis, by administering the vaccine to the piglets at an age of at most 28 days, preferably before the piglets are weaned.
    Type: Application
    Filed: August 2, 2018
    Publication date: July 2, 2020
    Applicant: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan JACOBS
  • Publication number: 20200046825
    Abstract: The present invention pertains to a combination of a first vaccine comprising non-replicating immunogen of porcine circo virus type 2 (PCV2) and non-replicating immunogen of Mycoplasma hyopneumoniae, and a second vaccine comprising live attenuated porcine reproductive and respiratory syndrome (PRRS) virus, for use in prophylactically treating an animal against an infection with porcine circovirus type 2, an infection with Mycoplasma hyopneumoniae and an infection with PRRS virus, by associated non-mixed administration of the first vaccine and the second vaccine to the animal. The invention also pertains to a kit-of-parts comprising the first and second vaccine and to a method of protecting an animal against such infections using these vaccines.
    Type: Application
    Filed: April 12, 2018
    Publication date: February 13, 2020
    Applicant: Intervet Inc.
    Inventors: Maarten Hendrik WITVLIET, Erwin van den BORN, Melanie SNO, Antonius Arnoldus Christiaan JACOBS
  • Publication number: 20190336594
    Abstract: The present invention pertains to a vaccine comprising an IgM protease antigen of Streptococcus suis, for use in a method wherein a female pig is vaccinated in order to protect a piglet against Streptococcus suis through the intake of colostrum of the vaccinated female pig.
    Type: Application
    Filed: April 17, 2019
    Publication date: November 7, 2019
    Applicant: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Patent number: 10265392
    Abstract: The present invention pertains to a vaccine comprising non live Lawsonia intracellularis antigen and a pharmaceutically acceptable carrier for use in a method to reduce in a pig the shedding of Lawsonia intracellularis bacteria associated with subclinical infection with Lawsonia intracellularis, by systemic administration of the vaccine to the pig.
    Type: Grant
    Filed: February 3, 2016
    Date of Patent: April 23, 2019
    Assignee: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Patent number: 10130699
    Abstract: The present invention pertains to a vaccine comprising in combination killed whole cell Lawsonia intracellularis bacteria and porcine circo virus 2 (PCV2) ORF2 protein for use in protecting a pig against an infection with Lawsonia intracellularis and PCV2 by an intradermal administration of the vaccine. The invention also pertains to a method to protect a swine against an infection with Lawsonia intracellularis bacteria and PCV2.
    Type: Grant
    Filed: December 2, 2014
    Date of Patent: November 20, 2018
    Assignee: Intervet Inc.
    Inventors: Antonius Arnoldus Christiaan Jacobs, Vicky Fachinger, Melanie Sno, Maarten Hendrik Witvliet
  • Publication number: 20180303924
    Abstract: The present invention pertains to a vaccine comprising inactivated Lawsonia intracellularis antigen for intradermal administration to an animal that has maternally derived antibodies directed against Lawsonia intracellularis, for use in a method to protect the animal against a disorder arising from an infection with Lawsonia intracellularis.
    Type: Application
    Filed: October 21, 2016
    Publication date: October 25, 2018
    Applicant: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Publication number: 20180021422
    Abstract: The present invention pertains to a vaccine comprising non live Lawsonia intracellularis antigen and a pharmaceutically acceptable carrier for use in a method to reduce in a pig the negative impact on average daily weight gain (ADWG) associated with subclinical infection with Lawsonia intracellularis, by systemic administration of the vaccine to the pig.
    Type: Application
    Filed: February 3, 2016
    Publication date: January 25, 2018
    Applicant: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Publication number: 20180000924
    Abstract: The present invention pertains to a vaccine comprising non live Lawsonia intracellularis antigen and a pharmaceutically acceptable carrier for use in a method to reduce in a pig the shedding of Lawsonia intracellularis bacteria associated with subclinical infection with Lawsonia intracellularis, by systemic administration of the vaccine to the pig.
    Type: Application
    Filed: February 3, 2016
    Publication date: January 4, 2018
    Applicant: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Patent number: 9662382
    Abstract: The present invention pertains to a vaccine comprising live attenuated Pasteurella multocida bacteria for protection of a ruminant against pneumonia caused by P. multocida by administration of the vaccine to the upper respiratory tract of the ruminant via intranasal atomization of the vaccine. The invention also pertains to a method to use the vaccine to protect a ruminant against pneumonia caused by P. multocida bacteria.
    Type: Grant
    Filed: November 28, 2013
    Date of Patent: May 30, 2017
    Assignee: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Patent number: 9642905
    Abstract: The present invention pertains to a vaccine for administration to the upper respiratory tract of a ruminant to protect said ruminant against pneumonia caused by Mannheimia haemolytica, the vaccine comprising in combination live attenuated Mannheimia haemolytica bacteria, live attenuated parainfluenza-3 virus and live attenuated bovine respiratory syncytial virus, wherein the vaccine is for administration to the upper respiratory tract of the ruminant via intranasal atomization of the vaccine.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: May 9, 2017
    Assignee: Intervet Inc.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Publication number: 20160303218
    Abstract: The present invention pertains to a vaccine comprising in combination killed whole cell Lawsonia intracellularis bacteria and porcine circo virus 2 (PCV2) ORF2 protein for use in protecting a pig against an infection with Lawsonia intracellularis and PCV2 by an intradermal administration of the vaccine. The invention also pertains to a method to protect a swine against an infection with Lawsonia intracellularis bacteria and PCV2.
    Type: Application
    Filed: December 2, 2014
    Publication date: October 20, 2016
    Applicant: Intervet Inc.
    Inventors: Antonius Arnoldus Christiaan Jacobs, Vicky Fachinger, Melanie Sno, Maarten Hendrik Witvliet
  • Publication number: 20160303219
    Abstract: The present invention pertains to a swine vaccine, in particular a vaccine comprising in combination live attenuated PRRS virus and inactivated Lawsonia intracellularis antigen, for the protection of a swine against an infection with PRRS virus and Lawsonia intracellularis bacteria. The invention also pertains to a method to protect a swine against an infection with PRRS virus and Lawsonia intracellularis bacteria using this vaccine.
    Type: Application
    Filed: December 2, 2014
    Publication date: October 20, 2016
    Applicant: Intervet Inc.
    Inventors: Christa Sibilla Drexler, Antonius Arnoldus Christiaan Jacobs
  • Publication number: 20160287690
    Abstract: The present invention pertains to a vaccine for administration to the upper respiratory tract of a ruminant to protect said ruminant against pneumonia caused by Mannheimia haemolytica, the vaccine comprising in combination live attenuated Mannheimia haemolytica bacteria, live attenuated parainfluenza-3 virus and live attenuated bovine respiratory syncytial virus, wherein the vaccine is for administration to the upper respiratory tract of the ruminant via intranasal atomisation of the vaccine.
    Type: Application
    Filed: March 16, 2014
    Publication date: October 6, 2016
    Applicant: INTERVET INC.
    Inventor: Antonius Arnoldus Christiaan Jacobs
  • Patent number: 9198963
    Abstract: The present invention pertains to the use of a non-live carbohydrate containing composition, the carbohydrate being also found in live Lawsonia intracellularis cells in association with the outer cell membrane of these cells, for the manufacture of a vaccine for protection against an infection with Lawsonia intracellularis, the vaccine being in a form suitable for systemic administration.
    Type: Grant
    Filed: July 17, 2013
    Date of Patent: December 1, 2015
    Assignee: Intervet International B.V.
    Inventors: Antonius Arnoldus Christiaan Jacobs, Paul Vermeij, Ruud Philip Antoon Maria Segers, Carla Christina Schrier